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Abstract
Mitochondria are organelles critical for cell survival because they produce ATP and mod-
ulate programmed cell death (PCD) pathways. PCD pathways are important in many 
clinical disorders, such as ischemia/reperfusion injuries, trauma, and toxic/metabolic syn-
dromes, as well as in chronic neurodegenerative conditions, such as amyotrophic lateral 
sclerosis, Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. Moreover, 
many viruses and other pathogens target the mitochondria. Viruses induce the produc-
tion of various proteins in their hosts that have proapoptotic and anti-apoptotic activities, 
depending on the cellular environment. More specifically, many viruses that target mito-
chondria regulate the balance between the anti- and proapoptotic Bcl-2 family proteins 
and thereby increase their own survival within the host cell. Recent studies indicated that 
mitochondria centralize several critical innate immune responses based on the presence 
of several important signaling proteins within the mitochondria: mitochondrial antiviral 
signaling (MAVS), stimulation of interferon genes (STING), and NLR family member X1. 
Therefore, mitochondria are not only vital because they regulate cell survival and death 
but also they have broad roles in the control of cell functions following pathogen inva-
sion. This chapter highlights the tight interplay between viral infection and mitochondria.
Keywords: virus, apoptosis, mitochondria, mitochondrial membrane potential (MMP), 
diseases, Bcl-2 family, viral death genes
1. Introduction
1.1. Viruses and hosts
Viral diseases are becoming increasingly common worldwide, so it is important to identify the 
causative species and examine the underlying pathogenesis to prevent future epidemics and 
reduce the spread of new diseases. Although many host responses can contribute to the patho-
genesis of viral diseases, little is known about the role of mitochondria in viral pathogenesis. 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Mitochondria are suitable targets for infectious microorganisms, such as viruses, because they 
act as powerhouses of the cell and have various other important functions. Therefore, “hijack-
ing” the mitochondria disrupts overall cell function and makes it easy for a virus to control 
the cell and propagate. The host, in turn, has several responses that it uses to protect itself 
from viral invasions. One defense mechanism is based on the immune system, and another is 
based on cell autonomy, in which cells undergo certain physiological changes upon the onset 
of infection, such as unscheduled activation of the cell cycle following induction by certain 
viral proteins. When an infected cell undergoes programmed cell death (PCD), which includes 
apoptosis, autophagy, and necroptosis, this can prevent the spread of the virus infection to 
neighboring cells. A further complication is that viruses often promote apoptosis, but they can 
also block apoptosis by interacting with different signaling molecules of the host cell. Many 
viruses, especially human viruses, can perform either function, depending on the underlying 
conditions. Recent studies have shown that most viruses force cells to undergo apoptosis. 
However, from the perspective of the virus, apoptosis of the host seems to provide no benefit, 
so this is a topic of the current research. Therefore, additional studies that elucidate the mecha-
nisms underlying the induction of the virus-induced PCD and cell lysis may help to identify 
new drug targets for the treatment of viral infections.
1.2. Intrinsic and extrinsic pathways of apoptosis in viral infections
Programmed cell death has a key role in the pathogenesis of many conditions including viral 
diseases, cancer, inflammation, and neurodegenerative diseases. Apoptosis is a highly complex 
process that is controlled by numerous cell signaling pathways [1]. The common event at the 
end point is activation of a set of cysteine-aspartic proteases (caspases) [2, 3]. Apoptosis may 
benefit host cells by limiting the production and dissemination of viruses [4]. However, apoptosis 
may benefit viruses if it allows them to increase production and dissemination of progeny [5, 6]. 
The PCD induced by a virus infection is often described as “typical apoptosis” [7]. However, 
recent studies reported that nonapoptotic forms of PCD are important for the pathogenesis of 
certain RNA viruses, including the JC virus, hepatitis C virus (HCV), coxsackievirus B3, entero-
virus, and dengue virus [8]. The mechanism of DNA virus-induced nonapoptotic cell death 
is not well understood. Although not all signaling pathways that induce apoptosis are fully 
understood, the fate of a cell undergoing apoptosis mainly depends on the balance between the 
Bcl-2 family sensor proteins, which can promote and inhibit apoptosis (Figure 1) [9–11]. Recent 
studies have shown viral pathogenesis that involves oxidative damage and apoptosis.
1.3. Role of ROS in viral diseases
Recent studies have shown that mitochondria are the targets of the reactive oxygen species 
(ROS) that are produced inside a cell during viral infections, and that mtDNA is a major target 
of these ROS [11]. Mitochondrial ATP generation requires proteins from the nuclear and mito-
chondrial genomes. ROS disrupt the oxidative production of ATP, which is required for nor-
mal cellular function, because damage of mtDNA disrupts the normal synthesis of proteins 
needed for mitochondria function and making them suitable targets for attack by ROS pro-
duced during infections by viruses and other microorganisms, although ROS also have other 
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cellular targets. In HIV and hepatitis C virus infections, oxidative stress (OS) always plays 
a dominant pathogenic role. Peterhen and other researchers showed that almost all viruses 
(DNA/RNA viruses) cause cell death by generating oxidative stress in infected cells [12–14]. 
The OS generated during chronic hepatitis is associated with hepatic damage, a decrease in 
reduced glutathione (GSH) and decrease in plasma and hepatic zinc concentration [15, 16]. 
In case of influenza virus infection, the activated phagocytes release not only produces ROS 
but also cytokine and TNF. The pro-antioxidant effect of TNF may be relevant to influenza 
virus as shown by children with Rey’s syndrome [17]. OS ultimately results in decrease in the 
functioning of the immune system.
Figure 1. Modulation of cell death pathways in mitochondria by different viral infections or different viral proteins. In 
the extrinsic apoptosis pathway (middle left) [2], is activation of Fas death receptors at the cell surface by its ligand for 
activating the caspase-8 for either cleaved Bid to tBid for targeting into mitochondria [24] or activates the ROS/RIP3-
mediated necroptosis via a nonmitochondria-mediated cell death process [2, 85]. In the intrinsic apoptosis pathway (top 
left), some death factors trigger death signals on disrupting mitochondrial function via loss of MMP and release the 
cytochrome c and activate the downstream caspase-3 for further triggering apoptotic cell death, but these mitochondria-
mediated death signaling also regulated by anti-apoptotic family members such as Bcl-2 and Bcl-xL for rescuing host 
cells [8, 10, 11, 87]. On the other hand, IAP can inhibit the caspase-3 activation [88] but it is suppressed by the Smac/
DIABLO molecule, which is released from mitochondria [24]. Finally, if viruses entering or expressing, they can also 
trigger proapoptotic signaling (indicated by black lines) or block anti-apoptotic signaling (indicated by red lines) via 
whole virus or viral gene productions in mammalian viruses, which is associated with activation of caspase-dependent [9] 
and caspase-independent executioner mechanisms [2], leads to cell death by viral genes from RNA and DNA viruses, 
respectively for inducing some damaged or human diseases [4, 27].
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2. Mitochondrial functions
Mitochondria are multifunctional organelles that are covered by an outer membrane (OM), 
within which lie the intermembrane space (IMS) and the inner membrane (IM). The IM is 
folded into special structures called cristae, so its surface area is much greater than that of the 
OM. The cristae function as matrices for protein complexes required for the electron transport 
chain (ETC), and they contain many integral membrane proteins, including adenine nucleotide 
translocator (ANT) and ATP synthase. The IM remains almost entirely impermeable under 
normal physiological conditions, thereby allowing the respiratory chain to create an electro-
chemical gradient. This electric potential is important for maintaining the mitochondrial mem-
brane potential (MMP, Δψm) of the IM. The pumping of protons by the ETC out of the IM 
activates ATP synthase, which phosphorylates ADP to ATP. The ATP generated on the matrix 
side of the IM is then exported by ANT in exchange for ADP. The OM has many voltage-
dependent anion channels (VDACs), which maintains permeability of solutes up to 5000 Da in 
size under normal physiological conditions. The IMS is chemically equivalent to the cytosol in 
terms of low molecular weight solutes and has its own special set of proteins. The human mito-
chondrial genome (about 16,500 bp), which is in the matrix (within the IM), only codes for 13 
subunits of the respiratory chain. More than 99% of mitochondrial proteins are encoded by the 
nuclear genome and then selectively imported into one of the mitochondrial compartments. 
Thus, the mitochondrial OM, IM, IMS, and matrix have highly unique protein compositions.
Mitochondria act “powerhouse” of the cell and have several other important functions. The 
numerous functions of mitochondria make them indispensable to the cell, so when a virus 
“hijacks” mitochondrial function, it allows it to control the whole cell. Mitochondria have 
important roles in several signal transduction pathways [18, 19], the process of aging [20], 
regulation of different biochemical pathways related to cell metabolism [21, 22], PCD [23, 24], 
development [25, 26], the pathogenesis of numerous diseases immune responses [19], and cell 
cycle control [19, 27]. The circular mitochondrial genome encodes 13 polypeptides, 2 rRNAs, 
and 22 tRNAs. All of these mtDNA products are essential for function of the ETC and the gen-
eration of ATP by oxidative phosphorylation [9, 27], although many proteins from the nuclear 
genome are also required. Thus, any injury to mtDNA can affect the whole cell. The mtDNA is 
more susceptible to damage from ROS because it lacks protective histones, the mitochondrion 
has more limited DNA repair enzymes, and it is close to ETC, the main center of ATP and 
ROS production. The matrix of IMS, which contains cytochrome c oxidase (Cyt C, encoded 
by mtDNA), SMAC/DIABLO (encoded by nuclear DNA), and endonuclease G (encoded by 
nuclear DNA), acts as a buffer zone between the IM and OM. This matrix region contains 
many of the enzymes needed for aerobic respiration, dissolved oxygen, water, carbon diox-
ide, and recyclable intermediates that serve as energy shuttles and have other functions.
2.1. Loss of mitochondrial membrane potential
A loss of the MMP (Δψm) leads to imbalances in the membrane potentials of the IM and OM, 
and then to arrest of normal cellular biosynthetic function and bioenergetics, and finally to a 
“crisis” within the cell. A loss of the MMP (Δψm) also leads to release of several proapoptotic 
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proteins from the IMS, such as Cyt C and Smac/DIABLO, as well as caspase independent 
death effectors, such as apoptosis-inducing factor (AIF) and endonuclease G (EndoG) [9], 
which have important roles in caspase-independent and caspase-dependent cell death [9]. 
The MMP (Δψm) transition occurs during the pathogenesis of exogenous factors (e.g., viral 
proteins, toxins, and prooxidants [9, 10]). A prolonged loss of the MMP (Δψm) leads to serious 
cell damage, from which the cell cannot recover. Therefore, in the intrinsic pathway of apop-
tosis, any viral factor that influences the MMP (Δψm) has a major impact on cell fate, either by 
inducing or by blocking cell death [9].
In recent years, there has been an increasing focus on the role of the MMP (Δψm) in dis-
ease and health. Thus, several recent models based on in vivo and in vitro studies explain the 
mechanisms underlying the maintenance and loss of the MMP. A loss of the MMP by any 
mechanism leads to functional and structural collapse of the mitochondria and cell death [27]. 
A recent study for first time has shown that dengue virus (DV) infection of human hepatoma 
cell line (HepG2) leads alteration in the bioenergetic function of mitochondrial morphology 
leading to MMP loss [28]. The alteration in respiratory properties of HepG2 cells in DV infec-
tion results due to decrease in respiratory control ratio (PCR) and ADP/O ratio, which sug-
gest significant alteration in mitochondrial morphology. Another additional feature observed 
by an increase in proton leak termed mitochondrial uncoupling which occurs by leaking of 
protons through F
o
F
1
 ATP synthase from inner membrane into matrix resulting in decrease in 
MMP loss. Thus, creating an imbalance in ATP synthesis ultimately affects the bioenergetic 
functions of cell. The biochemical mitochondrial damage induced in cell infected with HCV 
showed that E1 Protein together with core and NS3 are responsible for ROS production. Core 
and NS3 induce NO production which causes MMP loss by opening of transition pore [29]. 
NO could also interact with another free radical superoxide (O
2
−) to form strong peroxynitrite 
anion (ONOO–), which irreversibly inhibits multiple respiratory complexes (complexes I, II 
and IV) and aconitase, and activate proton leak and permeability transition pore [30, 31]. 
Therefore, interfering with energy metabolism by disrupting the ATP synthesis of cell results 
in modulation of mitochondrial function.
2.2. Effects of viral infections on mitochondrial processes
Mitochondria undergo a number of processes, such as fusion and fission, in normally function-
ing healthy cells. However, when mitochondria develop abnormalities, the cell can destroy it by 
the process of mitophagy [32]. Cells typically eliminate unhealthy mitochondria by mitochon-
drial fission; they typically use mitochondrial fusion to recycle matrix metabolites, including 
mtDNA and mitochondrial membranes, for the assembly of new and healthy mitochondria. 
Therefore, these three processes—mitophagy, fission, and fusion—are interlinked, and they all 
play prominent roles in maintaining healthy cells [33]. Mitophagy plays an important role in 
maintaining mitochondrial homeostasis, but can also eliminate healthy mitochondria in cases 
such as cell starvation, viral invasion, and erythroid cell differentiation [34, 35]. The mitochon-
drial fusion and fission are highly dynamic. Viruses interfere with these processes to distort 
mitochondrial dynamic to facilitate their proliferation. Thus, interfering with these processes 
promotes the interference of different cellular signaling pathways [36–38]. New castal virus 
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(NDV) uses strategy that interferes with P62-mediated mitophagy to promote viral propaga-
tion [39]. The severe acute respiratory syndrome coronovirus (SARS-CoV) escapes the innate 
immune response by translocating its ORF-9b to mitochondria and promotes proteosomal 
degradation of dynamin-like protein (Drp1) leading to mitochondrial fission [40]. However, 
still more studies are needed to explain the exact role of mitophagy in the viral disease patho-
genesis, which regulates the cell death process [41].
2.3. Role of mitochondria in host immune response
During the coevolution of viruses and hosts, some viruses have evolved proteins that mimic 
the activity of host proteins, thereby allowing the virus to complete its life cycle without induc-
ing an immune response in the host. For example, Mimivirus, a genus with a single species in 
the newly created Mimiviridae, has genes for many proteins, including a viral mitochondrial 
carrier protein (VMC-I) [42], which mimics the host cell’s mitochondrial carrier protein, allow-
ing it to control mitochondrial transport in infected cells. Therefore, this virus takes control of 
the host cell’s transportation of ADP, dADP, TTP, dTTP, and UTP in exchange for dATP, which 
the virus uses as an energy source for genome replication and production of progeny [27].
2.4. Viruses target mitochondrial DNA and disable host cells
Numerous viruses appear to have adopted a “strategy” of damaging the host cell mitochondrial 
DNA to control the whole cell. For example, the herpes simplex virus (HSV) causes productive 
and latent infections in human hosts by disruption of mitochondrial function. The HSV-1UL12 
gene encodes two distinct yet similar proteins, UL12 and UL12.5. UL12 is an alkaline nuclease, 
and UL12.5 is an N terminally truncated 500-aa polypeptide that lacks the first 126 residues 
of UL12. UL12 plays a crucial role in viral genome replication and processing; UL12.5 also 
has nuclease and strand-exchange activities but does not accumulate in the host cell nucleus. 
Instead, UL12.5 localizes predominantly to the mitochondria, where it triggers massive deg-
radation of mitochondrial DNA during early HSV replication. In particular, UL12.5 occurs 
directly within the mitochondrial matrix, and its nuclease activity degrades mtDNA [43]. HIV 
and hepatitis C virus infections cause metabolic stress due to mtDNA depletion in coinfected 
patients [44]. The Zta protein encoded by Ebola virus (EBV) genome translocates into mitochon-
dria and interacts with mitochondrial single-strand protein, which ultimately affects mtDNA 
replication [45]. The OS generated during HCV infection also interferes with mtDNA [31].
3. Human viruses in mitochondria-mediated diseases
3.1. Epstein: Barr virus
The Epstein–Barr virus (EBV) is an oncovirus that is associated with breast cancer, gastric can-
cer, and numerous other cancers. Recent studies showed that EBV-encoded latent membrane 
protein 2A (LMP2A) leads to increased mitochondrial fission [46]. Further, molecular studies 
showed that LMP2A activates the NOTCH pathway, which alters the expression of Drp1 and 
then increases mitochondrial fission. Although increased Drp expression does not directly 
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increase mitochondrial fission, the recruitment of Drp by mitochondria and activation of GTPase 
leads to mitochondrial fission. Therefore, the EBV-induced changes in mitochondrial function, 
due to the LMP2A protein, may play a major role in the pathogenesis of several cancers [47].
3.2. Herpes simplex virus (alphaherpesvirus)
Infections by the herpes simplex virus type 1 (HSV-1) and pseudorabies virus (PRV) lead 
to imbalances in the calcium homeostasis of host cells. A study on rodents indicated that 
this calcium imbalance leads to disruption of mitochondrial function in the cervical ganglion 
neurons [48]. An imbalance in the cellular calcium pool affects the Miro protein (a calcium-
binding protein), altering its interaction with kinesin-1. Therefore, HSV-1 and PRV “hijack” 
host cell proteins, and this disrupts mitochondrial dynamics, thereby allowing the viruses to 
replicate and spread to neighboring cells.
3.3. Influenza A virus
3.3.1. Influenza A virus induces oxidative stress in mitochondria
Reactive oxygen species have important roles in the overall function of normal cells and play 
a vital role in the host adaptive immune response [49, 50]. For example, production of O
2
.− is 
an important defense against microbial infections. However, a large increase in the produc-
tion of O
2
.−during influenza A virus infection leads to damage of lung parenchyma cells [51]. 
Further studies that OS increased lung injuries caused by the influenza virus and viral replica-
tion, irrespective of the viral strain [52, 53]. Excessive and nonspecific knockdown of stress-
related enzymes, such as superoxide dismutase 2 (SOD2), led to T-cell apoptosis and many 
developmental defects, resulting in overall weakening of the adaptive immune system and an 
increased susceptibility to influenza A virus subtype H1N1 [54, 55].
3.3.2. Influenza A virus-encoded protein PB1-F2 targets mitochondria
Influenza A viruses encode the proapoptotic protein PB1-F2, which localizes to the mitochon-
dria due to a target sequence on its C terminal domain. PB1-F2 is conserved within the influenza 
family [56]. After PB1-F2 binds to mitochondria, it interacts with two important mitochondrial 
proteins, VDAC1 on the OM and ANT3 on the IM [57, 58]. This leads to alterations in mito-
chondria morphology, release of proapoptotic proteins, loss of MMP, and then cell death.
3.4. HCV virus
3.4.1. HCV induces oxidative stress that damages mitochondria
HCV infection typically leads to generation of ROS, which interferes with the calcium signal-
ing pathways of the cell [9]. This disruption of calcium homeostasis alters the structure of the 
endoplasmic reticulum, and increased calcium is taken up by the mitochondria, leading to 
disruption of the MMP. Recent molecular studies have shown that many other HCV proteins, 
such as E2 [59], and NS4B [60], are important in generating oxidative stress. In addition, the 
nonstructural HCV protein NS5A is an integral membrane protein that is important for viral 
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replication, apoptosis, immune responses (such as interferon resistance), and changes in cel-
lular calcium [61]. The proteins NS5Aand NS3 have roles in increasing calcium uptake and in 
the oxidation of glutathione (GSH) to glutathione disulfide (GSSG) in mitochondria, which 
ultimately leads to oxidative stress [61–63]. The imbalance of ROS created in the mitochon-
dria leads to activation and translocation of NF-𝜅B and STAT3 to the nucleus, as part of dis-
ease progression. Antioxidants block the NS5A-mediated activation of NF-𝜅B and STAT3 [64]. 
NS4B also promotes translocation of NF-𝜅B to the nucleus in a PTK-mediated pathway. The 
resulting production of ROS and nitric oxide (NO) causes oxidative damage and inhibits DNA 
repair [60] and leads to apoptosis. ROS-mediated disruption of mitochondria is believed to be 
the sole cause of liver inflammation in HCV infections [9].
3.4.2. HCV-encoded proteins target mitochondria
HCV remains persistent in its host because it lowers the host cell immune response. The HCV 
protein NS3/4A is a serine protease that inhibits interferon beta production by the retinoic 
acid-inducible gene I (RIG-I) pathway. Studies of the NS3/4A protein show that this protease 
cleaves MAVS at Cys-508, a few residues before its mitochondrial targeting domain. Cleavage 
of MAVS inactivates this protein because its soluble form is not functional. NS3/4A has a 
mitochondrial localizing signal, so it can directly cleave MAVS in the mitochondria [65, 66]. 
Substitution of Cys-508 with arginine prevents cleavage of MAVS. Cleavage of MAVS is thus 
an important mechanism by which HCV reduces host cell defenses [66].
3.5. Hepatitis B virus targets mitochondria
Hepatitis B virus x protein (HBx) is potentially essential for viral replication, and it has onco-
genic properties in animal models [67]. HBx sensitizes hepatocytes to apoptosis induced by 
stimuli such TNF-α [68]. Studies of the overexpression of HBx showed that this protein causes 
apoptosis by causing a perinuclear clustering of mitochondria and a loss of the MMP [69]. 
Studies of HBx mutants identified that certain hydrophobic residues (a mitochondrial tar-
geting sequence, MTS) are important for its induction of mitochondrial localization, loss of 
MMP, and cell death [70]. The HBx protein usually interacts with at least two mitochondrial 
proteins, heat shock protein 60 (HSP60) [71] and HVDAC3 [72]. The interaction of HBx with 
these two proteins (which are important in maintaining mitochondrial integrity) ultimately 
disrupts mitochondrial function in infected cells. These two mitochondrial proteins play 
major roles in chronic liver disease and carcinogenesis. Therefore, HBx plays a major role in 
the pathogenesis of HBV infection due to its alteration of host cell mitochondria.
4. Control strategies
4.1. RNA interference treatment of viral diseases that target mitochondria
Despite the many advances in molecular biology and in treatment of viral diseases, the pre-
vention and control of viral infections remains a challenge. Alteration of the interaction of the 
virus and host is one general strategy. Therefore, a complete understanding of the interactions 
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of the host and virus at the molecular level is needed to develop new antiviral drugs and vac-
cines. There is an urgent need to find more effective therapeutic agents for the treatment of 
viral infections. Researchers have recently started testing treatments based on RNA interfer-
ence (RNAi), using either microRNA (miRNA) or small interfering RNA (siRNA). Although 
this approach is still in its infancy, there has been some success in silencing the viral genes 
responsible for virulence [73, 74].
RNAi is an endogenous defense that cells use as a defense against harmful nucleic acids, 
either generated by the cell itself or from external environment (such as a viral invasions) [75]. 
RNAi is successful against many virus infections, but the delivery and stability of RNAi mol-
ecules within the cell are major concerns. The stability of RNAi is affected by its charge and 
biochemical activity within a cell, so these two parameters must be considered when design-
ing RNAi-based therapies. In addition, the effectiveness of RNAi-based therapies depends on 
the delivery route [76], target gene [77, 78], target pathogen [75, 78], and target tissue [75]. The 
adverse effects of using RNAi-based treatment on the environment and treatment costs must 
also be considered, and we must have a deeper understanding of RNAi at the molecular level. 
The growing interest of molecular virologists in the use of RNAi suggests that this is one of 
the most exciting new therapeutic approaches for treatment of viral diseases [75].
4.2. Host antioxidant defense system fights viral invasion
The increased generation of ROS and reactive nitrogen species (RNS) is a key part of the 
pathogenesis of many virus infections. OS induces loss of the MMP, so mitochondria are 
become more susceptible to ROS damage. However, cells also have defenses against ROS, 
such as reduced glutathione (GSH),which acts as an antioxidant during the oxidative produc-
tion of ATP in healthy cells [9, 79–81]. An imbalance between the generation of ROS and ROS 
quenching by the cell’s endogenous antioxidant defense system usually leads to a disease and 
is common during viral invasion. In recent years, due to the unavailability of antiviral drugs, 
researchers have proposed a number of new strategies to protect against free radical-induced 
OS. These strategies may be characterized as repair and protection. Protection is achieved by 
enzymes and by nonenzymatic compounds, such as carotenoids, vitamin C, vitamin E, GSH, 
and flavonoids [82]. Recent studies have shown the importance of both classes of these mol-
ecules in defense against oxidative stress [9, 83–86].
5. Concluding remarks
Identifying the main cause of a new epidemic is the most important factor in controlling 
disease outbreak. Many host responses appear to contribute to the pathogenesis of viral infec-
tions, and recent cellular and molecular studies have shown that many viruses specifically 
target mitochondria. Several different host responses and viral proteins directly or indirectly 
act on the mitochondria and lead to loss of the MMP. Mitochondria play important roles 
in cell survival and cell death, so a better understanding how different viruses use mito-
chondrial responses to control cells may provide a foundation for the development of new 
treatments for different viral diseases. More specifically, clarification of the roles of viruses 
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and viral proteins in host mitochondria may help to develop methods that protect against 
pathogenic viruses. Therefore, molecular examination of the exact roles of viruses and viral 
proteins on mitochondria may help to guide the discovery of novel therapeutic strategies and 
provide important insights into different mitochondrial viral diseases. However, there are 
major unanswered questions regarding the mechanism of virus- and protein-induced loss of 
the MMP. Answering these questions may lead to the discovery of key molecules or pathways 
involved in loss of MMP, a common feature in the pathogenesis of many viral diseases. The 
research summarized in this review clearly shows that mitochondria are the main target of 
invading viruses, and that disruption of mitochondrial function is a major part of the patho-
genesis of viral diseases. Although the prevention and treatment of viral diseases is challeng-
ing, molecular pathogenesis studies examining virus-host interactions will help in the design 
of new drugs and therapeutic strategies against different viral diseases.
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DISC death-inducing signaling complex
ER endoplasmic reticulum
HCV hepatitis C virus
HBV hepatitis B virus
PLV poliovirus
KPSV Kaposi sarcoma virus
Bid BH3 interacting-domain death agonist
WDSV walleye dermal saecoma virus
HCMV human cytomegalovirus
EBV Epstein–Barr virus
SARS-CoV severe acute respiratory syndrome coronovirus
Mitochondrial Diseases452
VDAC voltage-dependent anion channel
HIV human immunodeficiency virus
IAPs inhibitor of apoptosis proteins.
Author details
Latif Reshi1,2, Hao-Ven Wang2 and Jiann-Ruey Hong1,3*
*Address all correspondence to: jrhong@mail.ncku.edu.tw
1 Lab of Molecular Virology and Biotechnology, Institute of Biotechnology, College of 
Bioscience and Biotechnology, National Cheng Kung University, Tainan City, Taiwan, ROC
2 Department of Life Sciences, College of Bioscience and Biotechnology, National Cheng 
Kung University, Tainan City, Taiwan, ROC
3 Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, 
Tainan City, Taiwan, ROC
References
[1] Liu J, Chen I, Kwang J. Characterization of a previously unidentified viral protein in 
porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. Journal 
of Virology. 2005;79:8262-8274
[2] Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science. 1998;281: 
1305-1308
[3] Münz C. Viral evasion of autophagy. Cell Host & Microbe. 2007;1:9-11
[4] Benedict CA, Norris PS, Ware CF. To kill or be killed: Viral evasion of apoptosis. Nature 
Immunology. 2002;3:1013-1018
[5] Wong J, Zhang J, Si X, Gao G, Mao I, et al. Autophagosome supports coxsackie virus B3 
replication in host cells. Journal of Virology. 2008;82:9143-9153
[6] Lee YR, Lei HY, Liu MT, Wang JR, Chen SH, et al. Autophagic machinery activated by 
dengue virus enhances virus replication. Virology. 2008;374:240-248
[7] Levine AJ. The cellular gatekeeper for growth and division. Cell. 1997;1997(88):323-331
[8] Rao L, White E. Bcl-2 and the ICE family of apoptotic regulators: Making a connection. 
Current Opinion in Genetics & Development. 1997;7:52-58
[9] Reshi L, Su YC, Hong JR. RNA viruses: ROS-mediated cell death. International Journal 
of Cell Biology. 2014;2014:467-452
Modulation of Mitochondria During Viral Infections
http://dx.doi.org/10.5772/intechopen.73036
453
[10] Reshi L, Wu JL, Wang HV, Hong JR. Aquatic viruses induce host cell death pathways 
and its application. Virus Research. 2016;211:133-144
[11] Reshi L, Wang HV, Hui CF, Su YC, Hong JR. Anti-apoptotic genes Bcl-2 and Bcl-xL 
overexpression can block iridovirus serine/threonine kinase-induced Bax/mitochondria-
mediated cell death in GF-1 cells. Fish & Shellfish Immunology. 2017;61:120-129
[12] Peterhans E, Grob M, Urge TB, Zanoni R. Virus-induced formation of reactive oxygen inter-
mediates in phagocytic cells. Free Radical Research Communications. 1987;3(1-5):39-46
[13] Vierucci A, DeMartino M, Graziani E. A mechanism for liver cell injury in viral hepatitis: 
Effects of hepatitis B virus on neutrophil function in vitro and in children with chronic 
active hepatitis. Pediatric Research. 1983;17(10):814-820
[14] Muller F. Reactive oxygen intermediates and human immunodeficiency virus (HIV) 
infection. Free Radical Biology and Medicine. 1992;13(6):651-657
[15] Boya P, Peña AD, Beloquietal O. Antioxidant status and glutathione metabolism in 
peripheral blood mononuclear cells from patients with chronic hepatitis C. Journal of 
Hepatology. 1999;31(5):808-814
[16] Bianchi GP, Marchesini G, Brizietal M. Nutritional effects of oral zinc supplementation 
in cirrhosis. Nutrition Research. 2000;20(8):1079-1089
[17] Cooperstock MS, Tucker RP, Baublis JV. Possible pathogenic role of endotoxin in Reye’s 
syndrome. The Lancet. 1975;1(7919):1272-1274
[18] Bossy-Wetzel E, Barsoum MJ, Godzik A, Schwarzenbacher R, Lipton SA. Mitochondrial fis-
sion in apoptosis, neurodegeneration and aging. Current Opinion in Cell Biology. 2003;15: 
706-716
[19] Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging and 
cancer: A dawn for evolutionary medicine. Annual Review of Genetics. 2005;39:359-407
[20] Chan DC. Mitochondria: Dynamic organelles in disease, aging and development. Cell. 
2006;125:1241-1252
[21] Hackenbrock CR. Ultrastructural bases for metabolically linked mechanical activity in 
mitochondria. I. Reversible ultrastructural changes with change in metabolic steady 
state in isolated liver mitochondria. Journal of Cell Biology. 1966;30:269-297
[22] Mannella CA, Pfeiffer DR, Bradshaw PC, Moraru II, Slepchenko B, et al. Topology of the 
mitochondrial inner membrane: Dynamics and bioenergetics implications. IUBMB Life. 
2001;52:93-100
[23] McBride HM, Neuspiel M, Wasiak S. Mitochondria: More than just a powerhouse. 
Current Biology. 2006;16:R551-R560
[24] Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. 
Physiological Reviews. 2007;87:99-163
[25] Mandal S, Guptan P, Owusu-Ansah E, Banerjee U. Mitochondrial regulation of cell cycle 
progression during development as revealed by the tenured mutation in drosophila. 
Developmental Cell. 2005;9:843-854
Mitochondrial Diseases454
[26] Honda S, Hirose S. Stage-specific enhanced expression of mitochondrial fusion and fis-
sion factors during spermatogenesis in rat testis. Biochemical and Biophysical Research 
Communications. 2003;311:424-432
[27] Reshi L, Hong JR. Mitochondria as a favourite organelle for invading viruses. Molecular 
Biology. 2017;6:181
[28] El-Bacha T et al. Mitochondrial and bioenergetic dysfunction in human hepatic cells 
infected with dengue 2 virus. Biochimica et Biophysica Acta (BBA)—Molecular Basis of 
Disease. 2007;1772(10):1158-1166
[29] Machida K et al. Hepatitis C virus infection activates the immunologic (type II) isoform 
of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular 
genes. Journal of Virology. 2004;78(16):8835-8843
[30] Hortelano S et al. Nitric oxide induces apoptosis via triggering mitochondrial perme-
ability transition. FEBS Letters. 1997;410(2-3):373-377
[31] Machida K et al. Hepatitis C virus triggers mitochondrial permeability transition with 
production of reactive oxygen species, leading to DNA damage and STAT3 activation. 
Journal of Virology. 2006;80(14):7199-7207
[32] Twig G, Shirihai OS. The interplay between mitochondrial dynamics and mitophagy. 
Antioxidants & Redox Signaling. 2011;14:1939-1951
[33] Chen H, Chan DC. Mitochondrial dynamics—Fusion, fission, movement, and mitophagy—
in neurodegenerative diseases. Human Molecular Genetics. 2009;18:R169-R176
[34] Shitara H, Kaneda H, Sato A, Inoue K, Ogura A, Yonekawa H, Hayashi JL. Selective and 
continuous elimination of mitochondria microinjected into mouse eggs from spermatids, 
but not from liver cells, occurs throughout embryogenesis. Genetics. 2000;156:1277-1284
[35] Ebato C, Uchida T, Arakawa M, Komatsu M, Ueno T, Komiya K, et al. Autophagy is 
important in islet homeostasis and compensatory increase of beta cell mass in response 
to high-fat diet. Cell Metabolism. 2008;8:325-332
[36] Seth RB et al. Identification and characterization of MAVS, a mitochondrial antiviral 
signaling protein that activates NF-κB and IRF3. Cell. 2005;122(5):669-682
[37] Castanier C et al. Mitochondrial dynamics regulate the RIG-I-like receptor antiviral 
pathway. EMBO Reports. 2010;11(2):133-138
[38] West AP, Shadel GS, Ghosh S. Mitochondria in innate immune responses. Nature 
Reviews Immunology. 2011;11(6):389
[39] Meng G, Xia M, Wang D, Chen A, Wang Y, Wang H, Yu D, Wei J. Mitophagy promotes 
replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung 
cancer cells. Oncotarget. 2014;5(15):6365-6374
[40] Shi C-S et al. SARS-coronavirus open reading frame-9b suppresses innate immunity 
by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. The Journal of 
Immunology. 2014;193(6):3080-3089
Modulation of Mitochondria During Viral Infections
http://dx.doi.org/10.5772/intechopen.73036
455
[41] Xia M, Meng G, Jiang A, et al. Mitophagy switches cell death from apoptosis to necrosis 
in NSCLC cells treated with oncolytic measles virus. Oncotarget. 2014;5(11):3907
[42] Monn’e M, Robinson AJ, Boes C, Harbour ME, Fearnley IM, et al. The mimivirus genome 
encodes a mitochondrial carrier that transports dATP and dTTP. Journal of Virology. 
2007;81:3181-3186
[43] Martinez R, Shao L, Bronstein JC, Weber PC, Weller SK. The product of a 1.9-kb mRNA 
which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth 
defects of a null mutant. Virology. 1996;215:152-164
[44] de Mendoza C, Sánchez-Conde M, Timmermans E, et al. Mitochondrial DNA depletion 
in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus 
ribavirin therapy. AIDS .2007;21(5): 583-588
[45] Wiedmer A, Wang P, Zhou J, et al. Epstein-Barr virus immediate-early protein Zta co-
opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit 
mitochondrial DNA replication. Journal of Virology. 2008;82(9):4647-4655
[46] Young LS, Rickinson AB. Epstein–Barr virus: 40 years on. Nature Reviews. Cancer. 2004;4: 
757-768
[47] Pal AD, Basak NP, Banerjee AS, Banerjee S. Epstein–Barr virus latent membrane protein-
2A alters mitochondrial dynamics promoting cellular migration mediated by Notch sig-
naling pathway. Carcinogenesis. 2014;35:1592-1601
[48] Kramer T, Enquist LW. Alphaherpesvirus infection disrupts mitochondrial transport in 
neurons. Cell Host & Microbe. 2012;11:504-514
[49] Rott R, Klenk HD, Nagai Y, Tashiro M. Influenza viruses, cell enzymes, and pathogenicity. 
American Journal of Respiratory and Critical Care Medicine. 1995;152(4):S16-S19
[50] Kido H, Sakai K, Kishino Y, Tashiro M. Pulmonary surfactant is a potential endogenous 
inhibitor of proteolytic activation of Sendai virus and influenza A virus. FEBS Letters. 
1993;322(2):115-119
[51] Hennet T, Peterhans E, Stocker R. Alterations in antioxidant defences in lung and liver of 
mice infected with influenza A virus. Journal of General Virology. 1992;3:39-46
[52] Geiler J, Michaelis M, Naczk P, et al. N-acetyl-l-cysteine (NAC) inhibits virus replication 
and expression of proinflammatory molecules in A549 cells infected with highly patho-
genic H5N1 influenza A virus. Biochemical Pharmacology. 2010;79(3):413-420
[53] Vlahos R, Selemidis S. NADPH oxidases as novel pharmacologic targets against influ-
enza A virus infection. Molecular Pharmacology. 2014;86(6):747-759
[54] Case AJ, McGill JL, Tygrett LT, Shirasawa T, Spitz DR, Waldschmidt TJ, Legge KL, 
Domann FE. Elevated mitochondrial superoxide disrupts normal T cell development, 
impairing adaptive immune responses to an influenza challenge. Free Radical Biology & 
Medicine. 2011;50(3):448-458
Mitochondrial Diseases456
[55] Allen RG, Balin AK. Oxidative influence on development and differentiation: An over-
view of a free radical theory of development. Free Radical Biology and Medicine. 1989;6(6): 
631-661
[56] Bruns K, Studtrucker N, Sharma A, Fossen T, Mitzner D, et al. Structural characterization 
and oligomerization of PB1-F2, a proapoptotic influenza A virus protein. The Journal of 
Biological Chemistry. 2007;282:353-363
[57] Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW. The influenza A virus PB1-F2 
protein targets the inner mitochondrial membrane via a predicted basic amphipathic 
helix that disrupts mitochondrial function. Journal of Virology. 2003;77:7214-7224
[58] Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P. Influenza virus PB1-F2 protein 
induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathogens. 2005;1:4
[59] Hsieh MJ, Hsieh YS, Chen TY, Chiou HL. Hepatitis C virus E2 protein induce reac-
tive oxygen species (ROS)-related fibrogenesis in the HSC-T6 hepatic stellate cell line. 
Journal of Cellular Biochemistry. 2011;112(1):233-243
[60] Li S, Ye Y, Yu X, et al. Hepatitis C virus NS4B induces unfolded protein response and endoplas-
mic reticulum overload response-dependent NF-𝜅B activation. Virology. 2009;391:257-264
[61] Liang Y, Ye H, Cong BK, HoS Y. Domain 2 of nonstructural protein 5A (NS5A) of hepa-
titis C virus is natively unfolded. Biochemistry. 2007;46:11550-11558
[62] Thoren F, Romero A, Lindh M, Dahlgren C, Hellstrand K. A hepatitis C virus-encoded, non-
structural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: Role of NADPH 
oxidase-derived oxygen radicals. Journal of Leukocyte Biology. 2004;76(6):1180-1186
[63] García-Monzón C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R. Intra-
hepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histo-
logical severity of liver disease. Journal of Hepatology. 2000;32(2):331-338
[64] Gong G, Waris G, Tanveer R, Siddiqui A. Human hepatitis C virus NS5A protein alters 
intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-𝜅B. 
Proceedings of the National Academy of Sciences of the United States of America. 
2001;98(17):9599-9604
[65] Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. Cardif is an adaptor pro-
tein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 2005;437: 
1167-1172
[66] Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. Hepatitis C virus protease NS3/4A cleaves 
mitochondrial antiviral signaling protein off the mitochondria to evade innate immu-
nity. Proceedings of the National Academy of Sciences of the United States of America. 
2005;102:17717-17722
[67] Wang Y, Lau SH, Sham JST, Wu MC, Wang T, et al. Characterization of HBV integrants 
in 14 hepatocellular carcinomas: Association of truncated X gene and hepatocellular car-
cinogenesis. Oncogene. 2004;23:142-148
Modulation of Mitochondria During Viral Infections
http://dx.doi.org/10.5772/intechopen.73036
457
[68] Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by 
tumor necrosis factor alpha. Proceedings of the National Academy of Sciences of the 
United States of America. 1997;94:8744-8749
[69] Takada S, Shirakata Y, Kaneniwa N, Koike K. Association of hepatitis B virus X protein 
with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading 
to cell death. Oncogene. 1999;18:6965-6973
[70] Henkler F, Hoare J, Waseem N, Goldin RD, McGarvey MJ, et al. Intracellular localization 
of the hepatitis B virus HBx protein. The Journal of General Virology. 2001;82:871-882
[71] Rahmani Z, Huh KW, Lasher R, Siddiqui A. Hepatitis B virus X protein colocalizes to 
mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its 
transmembrane potential. Journal of Virology. 2000;74:2840-2846
[72] Tanaka Y, Kanai F, Kawakami T, Tateishi K, Ijichi H, et al. Interaction of the hepatitis B 
virus X protein (HBx) with heat shock protein 60 enhances HBx-mediated apoptosis. 
Biochemical and Biophysical Research Communications. 2004;318:461-469
[73] Buchon N, Vaury C. RNAi: A defensive RNA-silencing against viruses and transposable 
elements. Heredity. 2006;96:195-202
[74] Rijiravanich E, Berezikov E. Small RNAs and the control of transposons and viruses in 
Drosophila. Trends in Microbiology. 2009;17:163-171
[75] Reshi ML, Wu JL, Wang HV, Hong JR. RNA interference technology used for the study 
of aquatic virus infections. Fish & Shellfish Immunology. 2014;40(1):14-23
[76] Attasart P, Kaewkhaw R, Chimwai C, Kongphom U, Namramoon O, Panyim S. Inhibition 
of white spot syndrome virus replication in Penaeus monodon by combined silencing of 
viral rr2 and shrimp PmRab7. Virus Research. 2009;145:127-133
[77] Shockey JE, O’Leary NA, de la Vega E, Browdy CL, Baatz JE, Gross PS. The role of crus-
tins in Litopenaeus vannamei in response to infection with shrimp pathogens: An in vivo 
approach. Developmental and Comparative Immunology. 2009;33:668-673
[78] Han-Ching Wang K, Tseng CW, Lin HY, Chen IT, Chen YH, Chen YM, et al. RNAi 
knock-down of the Litopenaeus vannamei Toll gene (LvToll) significantly increases mor-
tality and reduces bacterial clearance after challenge with Vibrioharveyi. Developmental 
and Comparative Immunology. 2010;34:49-58
[79] Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ. Glutamate-induced neuron 
death requires mitochondrial calcium uptake. Nature Neuroscience. 1998;1(5):366-373
[80] White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement 
use and colon cancer. Cancer Epidemiology Biomarkers and Prevention. 1997;6(10):769-774
[81] Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM. Lipoic acid as a potential ther-
apy for chronic diseases associated with oxidative stress. Current Medicinal Chemistry. 
2004;11(9):1135-1146
Mitochondrial Diseases458
[82] Sharoni Y, Danilenko M, Dubi N, Ben-Dor A, Levy J. Carotenoids and transcription. 
Archives of Biochemistry and Biophysics. 2004;430(1):89-96
[83] Schrauzer GN. Interactive effects of selenium and chromium on mammary tumor devel-
opment and growth in MMTV infected female mice and their relevance to human cancer. 
Biological Trace Element Research. 2006;109(3):281-292
[84] Packer L, Suzuki YJ. Vitamin E and alpha-lipoate: Role in antioxidant recycling and acti-
vation of the NF-𝜅B transcription factor. Molecular Aspects of Medicine. 1993;4(3):229-239
[85] Reshi ML, Hong JR. Role of oxidative stress in RNA virus–induced cell death. In: Shamimi A, 
editor. Reactive Oxygen Species in Biology and Human Health. New York: Taylor & 
Francis group; 2016. pp. 471-485
[86] Pryor WA. Vitamin E and heart disease: Basic science to clinical intervention trials. Free 
Radical Biology and Medicine. 2000;28(1):141-164
[87] Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nature Cell 
Biology. 2001;3:E255-E263
[88] Clem RJ, Duckett CS. The IAP genes: Unique arbitrators of cell death. Trends in Cell 
Biology. 1997;7:337-339
Modulation of Mitochondria During Viral Infections
http://dx.doi.org/10.5772/intechopen.73036
459

